Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
百度集團-SW
09888
5
京東健康
06618
| (FY)2024/12/31 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -2.24%12.29億 | -1.99%3.14億 | -1.70%3.13億 | 1.30%12.57億 | -4.82%3.07億 | 0.55%3.11億 | 4.84%3.21億 | 5.02%3.18億 | 2.65%12.41億 | 8.62%3.23億 |
| 主營業務成本 | ||||||||||
| 毛利 | -2.24%12.29億 | -1.99%3.14億 | -1.70%3.13億 | 1.30%12.57億 | -4.82%3.07億 | 0.55%3.11億 | 4.84%3.21億 | 5.02%3.18億 | 2.65%12.41億 | 8.62%3.23億 |
| 營業費用 | 0.17%11.63億 | 0.19%2.89億 | -3.16%2.8億 | 1.16%11.61億 | 3.25%2.99億 | -7.06%2.84億 | 2.92%2.89億 | 6.36%2.89億 | 15.79%11.48億 | 8.33%2.9億 |
| 員工成本 | -1.23%4.46億 | ---- | ---- | 3.89%4.51億 | ---- | ---- | ---- | ---- | 1.78%4.34億 | ---- |
| 銷售、一般行政及管理費用 | 3.73%4.12億 | ---- | ---- | 15.88%3.97億 | ---- | ---- | ---- | ---- | 14.02%3.43億 | ---- |
| -一般及行政管理費用 | 3.73%4.12億 | ---- | ---- | 15.88%3.97億 | ---- | ---- | ---- | ---- | 14.02%3.43億 | ---- |
| 折舊及攤銷 | -5.68%2,790.8萬 | ---- | ---- | 6.46%2,958.9萬 | ---- | ---- | ---- | ---- | 111.90%2,779.3萬 | ---- |
| -折舊 | -5.68%2,790.8萬 | ---- | ---- | 6.46%2,958.9萬 | ---- | ---- | ---- | ---- | 111.90%2,779.3萬 | ---- |
| 其他營業費用 | -2.00%2.78億 | ---- | ---- | -17.43%2.83億 | ---- | ---- | ---- | ---- | 36.71%3.43億 | ---- |
| 營業利潤 | -31.37%6,578.1萬 | -21.90%2,470.7萬 | 12.86%3,272萬 | 3.00%9,584.9萬 | -75.56%808.5萬 | 601.78%2,713.8萬 | 26.30%3,163.4萬 | -6.66%2,899.2萬 | -57.24%9,306.1萬 | 11.27%3,308.7萬 |
| 營業外利息收入與支出淨額 | 4,057.14%29.1萬 | 20,600.00%20.7萬 | 0.00%3,000 | 40.00%7,000 | 1,000 | 0.00%2,000 | 1,000 | 0.00%3,000 | -37.50%5,000 | 0 |
| 營業外利息收入 | 4,057.14%29.1萬 | 20,600.00%20.7萬 | 0.00%3,000 | 40.00%7,000 | --1,000 | 0.00%2,000 | --1,000 | 0.00%3,000 | -37.50%5,000 | --0 |
| 投資淨收益 | -1,550.00%-3.3萬 | -1.3萬 | -2.6萬 | 99.99%-2,000 | -73.62%-1,509.1萬 | 601.91%1,527.3萬 | ||||
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | -197.47%-5,184.5萬 | |||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | -63.72%-1,551.4萬 | -108.10%-947.6萬 | -917.8萬 | 0 | 65,610.67%1.17億 | |||||
| 減:其他特殊費用 | 69.03%1,551.4萬 | ---- | ---- | 107.85%917.8萬 | ---- | ---- | ---- | ---- | -35,119.46%-1.17億 | ---- |
| 減:勾銷 | --0 | ---- | ---- | --29.8萬 | --0 | --0 | ---- | ---- | --0 | ---- |
| 其他營業外收入(費用) | 21.1萬 | 3.1萬 | 9,900.00%10萬 | 1,000 | 24萬 | 16.8萬 | ||||
| 稅前利潤 | -41.26%5,073.5萬 | -20.44%2,493.2萬 | 13.11%3,279.6萬 | -39.74%8,637.4萬 | -100.97%-110萬 | 663.56%2,714.1萬 | 187.47%3,133.7萬 | 22.85%2,899.6萬 | -45.36%1.43億 | 329.17%1.14億 |
| 所得稅 | -25.09%2,043萬 | -13.85%966.6萬 | 17.98%1,133.3萬 | 34.11%2,727.3萬 | -101.72%-14.2萬 | 756.27%658.9萬 | 136.36%1,122萬 | 15.25%960.6萬 | -65.88%2,033.6萬 | 152.85%825.8萬 |
| 除稅後利潤 | -48.72%3,030.4萬 | -24.11%1,526.6萬 | 10.69%2,146.2萬 | -51.95%5,910萬 | -100.91%-95.8萬 | 639.14%2,055.2萬 | 226.95%2,011.7萬 | 27.00%1,938.9萬 | -39.32%1.23億 | 353.98%1.05億 |
| 持續經營利潤 | -48.72%3,030.5萬 | -24.11%1,526.6萬 | 10.69%2,146.3萬 | -51.95%5,910.1萬 | -100.91%-95.8萬 | 639.14%2,055.2萬 | 226.89%2,011.7萬 | 27.01%1,939萬 | -39.32%1.23億 | 353.98%1.05億 |
| 歸屬于少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | -48.72%3,030.4萬 | -24.11%1,526.6萬 | 10.69%2,146.2萬 | -51.95%5,910萬 | -100.91%-95.8萬 | 639.14%2,055.2萬 | 226.95%2,011.7萬 | 27.00%1,938.9萬 | -39.32%1.23億 | 353.98%1.05億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | -48.72%3,030.4萬 | -24.11%1,526.6萬 | 10.69%2,146.2萬 | -51.95%5,910萬 | -100.91%-95.8萬 | 639.14%2,055.2萬 | 226.95%2,011.7萬 | 27.00%1,938.9萬 | -39.32%1.23億 | 353.98%1.05億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | -48.74%10.21 | -24.04%5.15 | 10.55%7.23 | -51.95%19.92 | -100.90%-0.32 | 636.43%6.92 | 227.54%6.78 | 26.99%6.54 | -39.31%41.46 | 354.35%35.53 |
| 稀釋每股收益 | -48.67%10.21 | -24.08%5.14 | 10.57%7.22 | -51.97%19.89 | -100.90%-0.32 | 635.66%6.91 | 227.05%6.77 | 27.04%6.53 | -39.26%41.41 | 354.29%35.48 |
| 每股派息 | ||||||||||
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |